Last reviewed · How we verify
NCT04502485
Reduce Patient Discomfort With Water Exchange Method During Upper Endoscopy
NA trial testing Gastric water exchange in Patients Undergoing Diagnostic EGD in 250 participants. Status unknown.
30 June 2021
Quick facts
| Lead sponsor | Yu-Hsi hsieh |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 250 |
| Start date | 1 May 2019 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Gastric water exchange
- traditional air insufflation
Conditions studied
- Patients Undergoing Diagnostic EGD — all drugs for Patients Undergoing Diagnostic EGD →
Sponsor
Yu-Hsi hsieh
Who can join
Adults 20 to 65, any sex, with Patients Undergoing Diagnostic EGD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study was to evaluate the application of water exchange method to upper endoscopy. We hypothesize that water exchange during upper endoscopy could reduce patient discomfort. The primary outcome will be the patient discomfort score during upper endoscopy. The secondary outcomes will include cleanliness score, techniques adequacy score, findings of the EGD, and willing to repeat the procedure, as well as the patient and endoscopist satisfaction score with the method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04502485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04502485 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yu-Hsi hsieh
- Last refreshed: 6 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04502485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing